Effect of amylin on prolactin release

Area of Science:

• Endocrinology
• Neuroscience
• Metabolic Research

Background:

• Amylin is a peptide hormone co-secreted with insulin from pancreatic beta cells.
• It plays a role in glucose homeostasis and lipid metabolism.
• Amylin receptors are present in the rat central nervous system, but its effect on pituitary hormones is unknown.

Purpose of the Study:

• To investigate the effect of amylin on prolactin (PRL) secretion.
• To evaluate amylin's impact on PRL release both in vivo (central and peripheral administration) and in vitro using pituitary cell cultures in male Wistar Kyoto rats.

Main Methods:

• Intraventricular (i.c.v.) and intravenous (i.v.) injections of amylin in rats.
• In vitro incubation of pituitary cells with varying doses of amylin (1, 10, 100 nM).
• Measurement of prolactin concentrations using Radioimmunoassay (RIA).

Main Results:

• Central and peripheral amylin administration significantly decreased serum PRL levels after 120 minutes.
• In vitro, amylin (10 and 100 nM) significantly inhibited PRL release after 240 minutes.
• A dose- and time-dependent effect was observed, with 1 nM amylin increasing PRL after 60 minutes.

Conclusions:

• Amylin administration, whether central, peripheral, or in cell culture, inhibits prolactin release.
• These findings suggest amylin has a suppressive role in prolactin secretion.